Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nuedexta for neurobehavioral symptoms in adults with autism spectrum disorder
NCT01630811Phase 2Completed
- Sponsor
- Sutter Health
- Start
- Jan 2012
- Primary completion
- Dec 2015
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextromethorphan + quinidine in Autism Spectrum Disorder (ASD), sponsored by Sutter Health. Started Jan 2012; status: completed.
02
Drugs
dextromethorphan + quinidine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01630811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01630811.